cns tumors Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (3)

Phase 1 (1)
Phase 2 (1)
Unknown (1)

Interventional (3)

Mayo Clinic (1)
National Cancer Institute (NCI) (1)
Stergios Zacharoulis (1)

No (3)

No (3)

Adult (18+) (3)
Pediatric (Under 18) (3)

I am/have/had

I am/have/hadrefractory ependymoma

I am/have/hadpercutaneous endoscopic gastrostomy

I am/have/hadcytotoxic chemotherapy

I am/have/hadradiopharmaceutical therapy

I am/have/hadcoagulation disorder

I am/have/hadrecurrent melanoma

I am/have/hadrefractory malignant glioma

I am/have/hadeffects of radiation therapy

I am/have/haddiffuse intrinsic pontine glioma

I am/have/hadbone marrow procedure

I am/have/hadblood transfusion

I am/have/hadseizure disorder

I am/have/hadcancer treatment

I am/have/hadpleural effusion

I am/have/hadside effects of drugs

I am/have/hadcancer therapy

I am/have/hadmetastasis

I am/have/hadmedulloblastoma recurrent

I am/have/hadshake

I am/have/hadcns metastases

added new label for I am/have/had

I am looking for

I am looking forcorticosteroids

I am looking forinterferon

I am looking forcytokines

I am looking forpediatric

I am looking fortumor markers

I am looking fortipifarnib

I am looking forantineoplastic agents

I am looking forantineoplastic

I am looking fornitrosoureas

I am looking forhematopoietic growth factors

I am looking forradiopharmaceutical

I am looking forgrowth factor

I am looking formelanoma

I am looking forinterleukins

I am looking foriobenguane

I am looking for131i-mibg

I am looking foranticonvulsants

I am looking fornitrosourea

I am looking foranti-cancer agents

I am looking foranesthesia

added new label for I am looking for

Advanced Filters

Found 3 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

For pediatric ages
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Memantine for the Reduction of Cognitive Impairment After Radiation Therapy in Pediatric Patients With Central Nervous System Tumors

This early phase I trial studies the feasibility of giving memantine for the reduction of cognitive impairment after radiation therapy in pediatric patients with central nervous system tumors. Memantine may reduce the effects of radiation therapy on memory and thinking.

central nervous system tumors

cognitive impairment

effects of radiation therapy

memantine

direct bilirubin

0 views
19 Feb, 2024

Phase 2
For pediatric ages
For adults
Recruiting in 10s
Interventional Study
all
Endocrinology
Recruiting

Tipifarnib for the Treatment of Advanced Solid Tumors Lymphoma or Histiocytic Disorders With HRAS Gene Alterations a Pediatric MATCH Treatment Trial

This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphoma, or histiocytic disorders that have HRAS genetic alterations. Tipifarnib may block the growth of cancer cells that have specific genetic changes in …

refractory ependymoma

percutaneous endoscopic gastrostomy

radiopharmaceutical therapy

cytotoxic chemotherapy

recurrent melanoma

0 views
19 Feb, 2024

Phase 1
For pediatric ages
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

CED of MTX110 Newly Diagnosed Diffuse Midline Gliomas

The blood brain barrier (BBB) prevents some drugs from successfully reaching the target source. Convection-Enhanced Delivery (CED) is a method of direct infusion of drugs under controlled pressure to the tumor that may reduce systemic side effects of drugs in the patient. The purpose of this Phase I study is …

glioma

thromboplastin

coagulation disorder

serum pregnancy test

karnofsky performance status

0 views
19 Feb, 2024